Take a look at some of Thursday’s morning movers:
Bank of America - The bank earned 31 cents per share for the first quarter, excluding certain items, compared to estimates of 12 cents. Revenue was also above consensus, with the bank's provision for credit losses at the lowest levels since the third quarter of 2007.
Morgan Stanley - The firm earned 71 cents per share ex-items versus estimates of 44 cents, with revenues well above consensus. Morgan Stanley credits stronger wealth management revenue and lower costs.
Gilead Sciences - Gilead's experimental hepatitis C drug performed well in a clinical trial, possibly giving it a leg up in a rapidly growing market. Gilead acquired the drug when it paid nearly $11 billion to acquire drugmaker Pharmasset in November.
Travelers - The insurer earned $2.01 per share, ex-items, for the first quarter, versus estimates of $1.52. The company says it was able to raise prices successfully without hurting its customer retention rate.
Southwest Airlines - The airline lost 2 cents per share for the first quarter, a smaller loss than the 5 cents Wall Street analysts were anticipating. Southwest reported record revenue, with the AirTran acquisition contributing to that performance. CEO Gary Kelly tells CNBC that jet fuel costs were the overriding negative factor for the quarter.Page 1 of 5 | Next Page